Enterochromaffin-like (ECL) cells are histamine-containing endocrine cells in the gastric epithelium that show increased density during chronic atrophic gastritis. The current study determined cell number and apoptosis of isolated rat ECL cells in response to several growth factors. Isolated ECL cells from fundic mucosa (enrichment Ͼ90%) were grown in serum-free medium over 2-5 days. Cell number was determined by mitochondrial formazan production; apoptosis was measured by Tdt-mediated dUTP nick end labeling reaction and DNA fragmentation-based enzyme-linked immunosorbent assay. Immunocytochemistry and RT-PCR demonstrated the presence of epidermal growth factor receptor, neuronal growth factor receptor (type 1), and fibroblast growth factor (FGF) receptor (type 1). Gastrin (EC 50 , ϳ2 pM), transforming growth factor-␣ (TGF␣; 10 -30 ng/ml), and basic FGF (bFGF; 1-10 ng/ml) increased the total number of cultured ECL cells. bFGF augmented the gastrin (1 pM)-induced response. ␤-Neuronal growth factor (10 ng/ml) and bFGF (2 ng/ml) decreased the programed death of ECL cells. Interleukin-1␤ (100 pg/ml, 24 h) stimulated apoptosis 2-to 3-fold in ECL cells, and simultaneous incubation with TGF␣ (20 ng/ml) or bFGF (2 ng/ml) significantly inhibited this effect. ECL cells express specific receptors for gastrin, epidermal growth factor, neuronal growth factor, and FGF. bFGF prolonged ECL cell survival by inhibiting spontaneous apoptosis. Our data further indicate that TGF␣ and bFGF increase ECL cell number by inhibiting cytokine-induced programed cell death. (Endocrinology 139: 4380 -4390, 1998) 
ϳ2 pM), transforming growth factor-␣ (TGF␣; 10 -30 ng/ml), and basic FGF (bFGF; 1-10 ng/ml) increased the total number of cultured ECL cells. bFGF augmented the gastrin (1 pM)-induced response. ␤-Neuronal growth factor (10 ng/ml) and bFGF (2 ng/ml) decreased the programed death of ECL cells. Interleukin-1␤ (100 pg/ml, 24 h) stimulated apoptosis 2-to 3-fold in ECL cells, and simultaneous incubation with TGF␣ (20 ng/ml) or bFGF (2 ng/ml) significantly inhibited this effect. ECL cells express specific receptors for gastrin, epidermal growth factor, neuronal growth factor, and FGF. bFGF prolonged ECL cell survival by inhibiting spontaneous apoptosis. Our data further indicate that TGF␣ and bFGF increase ECL cell number by inhibiting cytokine-induced programed cell death. (Endocrinology 139: 4380 -4390, 1998) E NTEROCHROMAFFIN-LIKE (ECL) cells are histamineproducing endocrine cells in the gastric mucosa, constituting about 1% of the fundic epithelial cell volume (1, 2) . This cell regulates gastric acid secretion by integrating neuronal and hormonal signals (1) (2) (3) (4) . In vivo, ECL cells proliferate under certain conditions (5) (6) (7) (8) . Most prominently, reversible hyperplasia and increased ECL cell number are observed during antisecretory therapy (9) or primary hypergastrinemia (i.e. Zollinger-Ellison syndrome). During inhibition of gastric acid secretion in rats, ECL cell density increases after 2-14 days in close correlation to the rise in systemic serum gastrin levels (5, 6) . After this period, cell quantity remains unchanged (5) .
Moreover, ECL cells reveal prominent persistence during chronic atrophic gastritis. This type of gastritis is caused by autoimmune mechanisms (classical type A gastritis) or by long term Helicobacter pylori infection. Autoimmune gastritis is characterized by severe atrophy of parietal and peptic cells and is associated with the production of autoantibodies against parietal cells and intrinsic factor (10 -14) . Dysplasia, microclusters, and even carcinoid formations are observed during autoimmune gastritis (10 -15) . Atrophy of gastric mucosal cells with persistence of endocrine cells is also observed during multifocal gastritis caused by certain subtypes of H. pylori-inducing atrophy and hypochlorhydria after years of infection (14, 16 -20) . The reason for the persistence of ECL cells is still unknown. Several investigators have proposed that ECL cell dysplasia and carcinoids evolve independently of the reversible ECL cell hyperplasia during antisecretory therapy and hypergastrinemia (13, 15) .
In the chronically inflamed mucosa, there is increased production of proinflammatory cytokines and growth factors paralleled by elevated serum gastrin levels (16, 17) . Therefore, the proliferative and apoptotic responses of epithelial cells might be altered by hypergastrinemia, growth factors, or cytokines released from lymphocytes or epithelial cells. The antral hormone gastrin or mucosal growth factors may act as direct stimulants of ECL cell growth by enhancing cell mitosis and DNA synthesis. Active proliferation of rat gastric ECL cells has been observed in response to gastrin under in vivo and in vitro conditions and is mediated by increased DNA synthesis (4, 6 -8, 21-24) . Stimulation of bromodeoxyuridine (BrdU) incorporation was also observed in isolated ECL cells in the presence of transforming growth factor-␣ TGF␣ (21) . In the case of malignant transformation, ECL cells stimulate their own growth in vivo by autocrine growth factor production (25, 26) , specifically reported for epidermal growth factor (EGF)/TGF␣, insulin-like growth factor type I, and basic fibroblast growth factor (bFGF). The receptor subtypes for these growth factors and the corresponding ligands, however, have only been characterized in malignant tissues (25) (26) (27) (28) . Therefore, these growth factors and the corresponding receptors might also play an important role in ECL cell proliferation under normal conditions.
Alternatively, a relative increase in ECL cells may be due to enhanced cell survival after inhibition of programed cell death, i.e. apoptosis (29) . Neuronal growth factor (NGF), for example, is an important inhibitor of programed cell death in chromaffin cells and plays a crucial role in the development of sympathetic and sensory neurons (30) . Apoptosis is a process of active cellular self-destruction observed in all eukaryotic cells and reflects changes in the cytological and genetic structures (29) . Induction of apoptosis is an active, genetically regulated process and requires the coordinated expression of specific genes. Necrosis, in contrast, is a passive process. Up until now, induction of apoptosis in ECL cells and its regulation by growth factors or proinflammatory cytokines have not been determined. As the ECL cell number in vivo or in vitro can be increased by active cellular proliferation or by enhanced cell survival, it is possible that growth factors also affect cell density by inhibition of programmed cell death.
The present study was designed to investigate the presence of various growth factor receptors and to point out the effects of the corresponding growth factors on ECL cell apoptosis. Isolated rat ECL cells were used as an in vitro model that enables us to study direct effects of added substances on a defined cell population. In this model, mast cells and other endocrine cells, such as enterochromaffin (EC-) cells, are absent and do not interfere (2) . We investigated total ECL cell number in response to growth factors to determine their potential effects on ECL cell growth or enhanced cell survival. DNA fragmentation in ECL cells undergoing apoptosis was determined in single cells by TdT-mediated dUTP nick end labeling (TUNEL) reaction and by a semiquantitative enzyme-linked immunosorbent assay (ELISA). Our results suggest that growth factors act in two ways to increase ECL cell number: via direct effects on active cell proliferation or via indirect effects on cell survival. Growth factor effects become more evident in the presence of proinflammatory cytokines, which may parallel clinical findings during chronic atrophic gastritis in humans.
Materials and Methods

Cell isolation and primary culture
The stomachs of female Sprague-Dawley rats were prepared (6 weeks old, 150 -200 g) by the everted sac method (total of 160 preparations, 5 rats/preparation) as previously described (3, 4, 9, 31) . Enzymatically dispersed cells (pronase E, 1.3 mg/ml; Boehringer Mannheim, Mannheim, Germany) were subjected to counterflow elutriation (JE-6 elutriator rotor, Beckman Instruments, Palo Alto, CA) and to subsequent density gradient centrifugation (Accudenz, Accurate Chemicals, Westbury, NJ). Enriched ECL cells were then placed on 6-well plates precoated with Matrigel (Becton Dickinson, Heidelberg, Germany) at a 1:5 dilution. Initially, cells were allowed to recover by culturing for 24 h in DMEMHam's F-12 (DMEM/F12), supplemented with 5% FBS, 2% BSA, 10 mg/liter gentamicin, 100 nm hydrocortisone, and 1 pm gastrin. After 24 h, the initial medium was replaced by DMEM/F12 supplemented with 2 mg/liter sterile BSA, 10 mg/liter gentamicin, 100 nm hydrocortisone, N1 supplement (Sigma, Munich, Germany; 5 mg/liter insulin, 5 mg/liter transferrin, 5 mg/liter sodium selenite, 7.3 mg/liter progesterone, and 1.6 g/liter putresceine), and 1 pm gastrin. The number of viable ECL cells was also determined after 96 h of culture by trypan blue exclusion. Cells were cultured in 6-well plates, removed from the plates by trypsinization, and counted in a Neubauer cell chamber (Brand, Wertheim, Germany). ECL cell purity in this cultured cell preparation was greater than 90%, as determined by acridine orange uptake and specific antibody staining using the antihistidine decarboxylase antibody, as reported previously (3, 4, 9, 31).
PCR amplification using an ECL cell complementary DNA (cDNA) library
RNA was extracted from enriched ECL cells after the initial isolation step (2 ϫ 10 7 cells, harvested from 20 preparations), and an ECL cell cDNA library was prepared as previously described using the phage vector (3, 4) . Amplification of the gastrin, EGF, FGF, and NGF receptor messages was carried out using specific primers for each of the known receptor sequences in rats. Primers were as follows: gastrin receptor, 5Ј-GCAGCACCAGGGC-CTGTCCACA-3Ј (sense) and 5Ј-TTCTCCAATCTCCCAACCCCTCAC-3Ј (antisense); EGF receptor, 5Ј-GCTGGGGAGAGGAGAACT-3Ј (sense primer) and 5Ј-GCAGGGCCCGTCACATTTTT-3Ј (antisense primer); FGF receptor subtype I, 5Ј-T-TCTCCAATCTCCCAACCCC-3Ј (sense) and 5Ј-GCAGCACCAGGGCCTGTCCA-3Ј (antisense); NGF receptor, 5Ј-AAGGGGCGGGGCATTGTGGTA-3Ј (sense) and 5Ј-CCGTGTTGGCT-TCAGGCTTATGC-3Ј (antisense); and hepatocyte growth factor receptor (HGF; c-met), 5Ј-GCCCGGCCCTCTTCAGTTTAG-3Ј (sense) and 5Ј-TTG-GAGGATGGGCCGTTGTGTT-3Ј (antisense). PCR was performed using the Prime Zyme Kit (Biometra, Gottingen, Germany) and the following temperature cycle profile: denaturation for 2 min at 95 C, followed by 30 -35 cycles of annealing for 1 min at specific primer temperature, extension for 1 min at 72 C, denaturation for 1 min at 95 C, and termination by 7 min at 72 C. The exact cycle length and annealing temperatures are specified in Results. Horizontal 1.9% agarose gel electrophoresis (ultrapure agarose, Life Technologies, Heidelberg, Germany) was performed. Primers were selected by software analysis using the receptor sequences available on Gene Works (IntelliGenetics, Campbell, CA). All amplification products were eluted from the agarose gel using a QIAEX II Gel Extraction Kit (Qiagen, Hilden, Germany) and were sequenced by a commercial institute (MediGene, Martinsried, Germany). PCR products revealed homology to the known receptor sequences. Negative controls were performed as follows. In one of the controls performed during PCR analysis, no cDNA was added because a cDNA library from isolated cells was used as a template (commercially performed by Invitrogen, San Diego, CA). In this system, amplification of DNA is excluded (32) . In another negative control, no cDNA but the remaining PCR constituents were added to exclude contamination within the PCR reaction. RNA was isolated, followed by a deoxyribonuclease digest, and PCR was performed without the addition of reverse transcriptase. In the following step, RNA and the reaction product obtained without reverse transcriptase addition were used as substrate for PCR. None of these samples gave a base pair product.
Immunocytochemistry
Isolated, purified ECL cells (4 -5 ϫ 10 4 /slide) were incubated for 48 h on glass slides coated with Cell-Tak (Becton Dickinson; 1:1 dilution with 0.5 m NaHCO 3 ) in DMEM culture medium. Subsequently, culture medium was removed, and staining was performed with fluorescein isothiocyanate (FITC)-conjugated antibodies or with the avidin-biotinylated enzyme complex method (Vector Laboratories, Burlingame, CA). Staining for the EGF receptor was performed by fixing cells in phosphate-buffered formaldehyde (3.7%) at room temperature for 12 min and washing three times in PBS (0.15 m). Cells were incubated with the polyclonal antihuman EGF receptor at a 1:50 dilution (Upstate Biotechnology, Lake Placid, NY) for 3 h at 37 C. Slides were washed in PBS, and the secondary FITC-conjugated secondary antibody (1:200) was added for 1 h at room temperature. PC12 cells were used as a positive control for EGF receptor staining. Negative controls were performed under identical conditions without adding the primary antibody. Staining for the FGF receptor was performed in cells fixed with 4% paraformaldehyde for 10 min, and incubation with polyclonal antichicken FGF receptor antibody (1:25; Upstate Biotechnology) was performed for 1 h at room temperature. Swiss 3T3 cells were used as a positive control. Specific antibody binding was visualized by secondary staining with a FITC-conjugated antirabbit antibody (Sigma). Immuocytochemistry for NGF receptor was performed by fixing the cells in acetone at Ϫ20 C for 10 min and incubating with a monoclonal antibody at a dilution of 1:10 (Becton Dickinson) at room temperature for 1 h. Bound antibodies were localized using the enzyme complex method. PC12 cells were used as a positive control.
Immunocytochemistry for autocrine TGF␣ or bFGF production was performed by fixing cultured cells with acetone (50%)-methanol (50%) for 2 min. Subsequently, cells were incubated with anti-TGF␣ or anti-bFGF antibody [Calbiochem (Cambridge, MA) or Upstate Technologies, respectively] at a dilution of 1:10 for 2 h at room temperature. Staining was visualized using a biotinylated antirabbit IgG secondary antibody and subsequent peroxidase staining.
Measurement of ECL cell number
ECL cell number was measured using a commercially available kit. This procedure determines mitochondrial formazan production in living cells that are capable of reducing a yellow-colored tetrazolium salt into a red-colored formazan derivative (EZ4Y kit, Biomedica, Vienna, Austria). The EZ4Y kit determines the increase in cell quantity after the addition of a growth factor of interest, but does not differentiate between active proliferation or passive survival of cells. The OD is linearly correlated with cell number; 0.05 U corresponds to 5 ϫ 10 3 cells, and 0.1 U corresponds to 1 ϫ 10 4 cells. These studies were performed with ECL cells that were cultured in 96-well plates precoated with Matrigel (dilution 1:5) at approximately 11,000 cells/well. After 24 h, the initial growth medium was replaced by a serum-free DMEM medium supplemented with 2% BSA, 1% N1 supplement, 1 pm gastrin, 10 mg/ml gentamicin, and 100 nm hydrocortisone. The influence of gastrin, TGF␣, bFGF, or ␤NGF was determined by addition of the growth factor of interest to the culture medium. Incubation was carried out over 72 h, and 25 l of the dye substrate were added subsequently to each well. OD was recorded at 450 nm using a microplate reader (Bio-Rad, Munich, Germany) after 4 h, showing significant differences in metabolic capacity. Data are expressed as the relative increase as a percentage of the basal value.
Determination of ECL cell apoptosis
Two different techniques were used for the determination of ECL cell apoptosis. First, the in situ cell death detection kit, which is based on the TUNEL reaction, was used to determine ECL cell death (POD, Boehringer Mannheim, Mannheim, Germany). Isolated ECL cells were cultured over 24 h on Cell-Tak (dilution 1:1 with 0.5 m NaHCO 3 )-coated glass slides. After 24 h, the initial culture medium was removed, and DMEM/F12 medium was added for another 24 h with vehicle, the growth factor of interest, or, alternatively, with vehicle, interleukin-1␤ (IL-1␤; 100 pg/ml), or IL-1␤ with the growth factor of interest. Subsequently, cells were fixed in Bouin's solution over 15 min. DNA strand breaks, generated by apoptosis, were detected in ECL cells by incubation with biotinylated nucleotides and end labeling with terminal transferase reaction. Staining was visualized using peroxidase reaction.
Second, a photometric immunoassay for in vitro determination of histone-associated DNA fragmentation was performed. This kit is based on a quantitative sandwich enzyme immunoassay using mouse monoclonal antibodies directed against histone complexes associated with DNA breaks, which can be detected during programmed cell death (cell death detection ELISA, Boehringer Mannheim, Ingelheim, Germany). Isolated ECL cells were cultured over 24 h on Matrigel-coated six-well plates, incubated with vehicle or stimulants over 24 h, trypsinated, washed with PBS, and lysed. Antibody binding with subsequent peroxidase reaction was measured in an ELISA reader at a wavelength of 405 nm.
Statistical analysis
Results are shown as the mean Ϯ sem. Data were analyzed by Student's t test. P Ͻ 0.05 was considered significant.
Results
1) Characterization of serum-free, N1-supplemented medium
To eliminate the influence of growth factors present in FBS-supplemented culture medium, FBS was replaced by a new culture supplement (N1 supplement, Sigma) (4, 9, 31). After cell isolation and purification, cells were allowed to recover by culture for 24 h in DMEM/F12 supplemented with 5% FBS, 2% BSA, 10 mg/liter gentamicin, 100 nm hydrocortisone, and 1 pm gastrin. After 20 h, the initially applied medium was replaced by DMEM/F12 containing 2% BSA, 10 mg/liter gentamicin, 100 nm hydrocortisone, N1 supplement at a 1:100 dilution, and 1 pm gastrin. Preliminary experiments (n ϭ 12) demonstrated that ECL cells survived a culture period of 4 -6 days in N1-supplemented medium. The survival rate of ECL cells after 96 h of short term culture was determined by trypan blue exclusion and was identical to the survival rate after incubation with FBS. In addition, gastrin-induced histamine release (after 48 h of culture; not shown) and ECL cell number in the presence of gastrin (see below) were determined in N1-supplemented medium (after 96 h of culture) and were identical to the results obtained after incubation in FBS (data detailed below in part 3 of Results).
2) PCR of ECL cell complementary DNA library (Fig. 1)
The PCR reaction was performed using a ECL cell complementary DNA library as template and specific primers for the rat gastrin, EGF, FGF (subtypes I and IV), NGF, and HGF receptors. In lane 1 of Fig. 1 , PCR of the gastrin receptor is shown. We generated primers assuming the presence of the long isoform receptor (33) . The PCR reaction for the rat sequence yielded a primer product of the expected size (563 bp) and, therefore, determined the long isoform (452 amino acids) of the rat gastrin receptor in the rat ECL cell cDNA library. This product corresponded to the human sequence and to the previously published sequence of the cholecystokinin-B receptor in rat brain (33, 34) . Lane 2 shows the negative control for the rat gastrin receptor performed without cDNA. Lanes 3, 5, and 7 show the PCR results with specific primers for the rat EGF (lane 3), FGF (lane 5; subtype I), and NGF (lane 7) receptors and using the identical cDNA library from ECL cells as template (n ϭ 3 independent experiments). Lanes 4, 6, and 8 present the corresponding negative controls. For the rat EGF receptor (lane 3), the annealing temperature was 60 C, and 35 cycles were performed, yielding a product of 404 bp. For the rat FGF receptor subtype 1 (lane 5), the annealing temperature was 63 C, and amplification was carried out over 30 cycles, revealing a product of 506 bp. Receptor subtype IV was not detected. For rat NGF receptor subtype 1 (lane 7), the annealing temperature was 63 C at 30 cycles, yielding a product of 481 bp (n ϭ 3 for each PCR experiment). All bands were eluted from the gels, sequenced, and found to be homologous to the sequences known from other rat tissues. PCR was also performed with primers specific for the rat HGF receptor (c-met protooncogene), but no specific product was obtained (n ϭ 3; not shown).
3) Immunocytochemistry of growth factor receptors on ECL cells (Fig. 2)
Three to 4 ϫ 10 4 cells were cultured on Cell-Tak-coated glass slides and incubated in N1-supplemented DMEM. Specific antibody staining was performed with isolated ECL cells after 48 h of primary culture in a total of 15 independent experiments. Figure 2a shows formalin-fixed cells incubated with a polyclonal antihuman EGF receptor antibody (dilution 1:50). Binding was visualized with an antisheep FITC-conjugated secondary antibody. A positive control was performed with PC12 cells, stained by indirect immunofluorescence (Fig. 2b) . A negative control was performed by omission of the first antibody (Fig. 2c) . Figure 2d control was performed in Swiss 3T3 cells (Fig. 2e) . Figure 2f shows the negative control for the FGF-R. Figure 2g presents acetone-fixed ECL cells stained with the antirat NGF receptor monoclonal antibody (dilution 1:10). Staining was visualized using a biotinylated antimouse antibody and peroxidase staining with diaminobenzidine. The positive control was performed using PC12 cells (Fig. 2h) , and the negative control was performed without addition of the first antibody (Fig. 2j) . (Fig. 3 and Table 1) ECL cells were isolated and cultured over a total of 96 h. After 24 h, the initially applied culture medium was replaced by N1-supplemented medium. No gastrin was added to the medium for studying control cells (basal conditions), whereas, alternatively, gastrin was added at concentrations of 10 Ϫ13 -10 Ϫ8 m (n ϭ 4; Fig. 3A ). The metabolic capacity of cultured ECL cells was determined under basal conditions or during gastrin or growth factor stimulation. The increase in OD using the EZ4Y kit served as a parameter for the total amount of living cells. After a total 96-h culture, OD ranged from 0.025-0.05 U, corresponding to 2.5-5 ϫ 10 3 cells. In Fig. 3 , A-E, results are shown as the relative increase in the OD above basal values. Gastrin (Fig. 3A) dose dependently stimulated ECL cell number and increased the number of living cells 2-to 3-fold, as indicated by increasing optical density at 450 nm. The maximal effect was observed at 10 Ϫ11 m gastrin, similar to the results of previous experiments performed with FBS (4). The EC 50 was about 2 pm gastrin (n ϭ 4 independent experiments).
4) Measurement of ECL cell number by formazan production and cell count
TGF␣ also increased the number of ECL cells (tested at a concentration of 10 -30 ng/ml), with a maximal effect at 20 ng/ml ( Fig. 3B ; n ϭ 5) after 96 h of incubation. There was no additive effect of TGF␣ applied in combination with gastrin (data not shown; n ϭ 5). bFGF increased ECL cell number after 96 h of incubation, and the maximal response was observed at a concentration of 2 ng/ml (P Ͻ 0.05 vs. basal; Fig. 3C ; n ϭ 5 independent experiments). bFGF (5 ng/ml) produced additive effects in combination with gastrin (10 Ϫ12 m; n ϭ 5 independent experiments; Fig. 3D ). No significant increase in ECL cell quantity was observed after incubation with ␤NGF (n ϭ 5; Fig. 3E ; 1-100 ng/ml). Similarly, no significant increase was observed after incubation with HGF (1-60 ng/ml; data not shown; total of n ϭ 6 independent experiments).
In a separate set of experiments (n ϭ 5), ECL cells were isolated and cultured on six-well plates. Cell numbers were determined after the addition of vehicle, gastrin (10 Ϫ11 m), bFGF (2 ng/ml), and TGF␣ (20 ng/ml) after 72 h of incubation. Following cell removal from the six-well plates, the t test) . B, TGF␣ stimulated the mitochondrial formazan production. The maximal effect was observed at 20 ng/ml (n ϭ 5). **, P Ͻ 0.01 (by unpaired t test). C, FGF increased OD in primary culture of ECL cells, and the maximal response was observed at 2 ng/ml (n ϭ 5). **, P Ͻ 0.01; *, P Ͻ 0.05 (by unpaired t test). D, Gastrin (10 Ϫ12 M) showed an additive effect in combination with bFGF (5 ng/ml; n ϭ 5). *, P Ͻ 0.05 (by unpaired t test). E, ␤NGF had no significant effect on ECL cell number.
number of living cells was counted after trypan blue exclusion. The total number of trypan blue-negative cells was counted using a Neubauer chamber. All three growth factors stimulated ECL cell number, corresponding to the results using formazan incorporation (Table 1) . (Fig. 4) Programmed cell death of ECL cells was determined under resting conditions and in the presence of growth factors using the TUNEL reaction (Fig. 4A) or a DNA fragmentation ELISA (Fig. 4B) . For analysis of the TUNEL reaction, cells were counted in visual fields with more than 100 cells and expressed as a percentage of cells with positive staining. After 24 h of recovery, purified ECL cells were incubated for another 24 h with vehicle, TGF␣ (20 ng/ml), gastrin (10 pm), ␤NGF (10 ng/ml), or bFGF (2 ng/ml). As shown in Fig. 4A , the spontaneous apoptotic rate ranged from 4 -6% of ECL cells in N1-supplemented medium. Gastrin and TGF␣ had no significant effect on ECL cell death. ␤NGF significantly decreased the basal rate (n ϭ 6; P Ͻ 0.05). bFGF was the most effective growth factor tested and reduced the apoptosis rate of ECL cells to 3-4% (reduction of 33%; n ϭ 6; P Ͻ 0.01).
5) Control of spontaneous apoptosis by gastrin, TGF␣, ␤NGF, or bFGF
The growth factor effects on spontaneous ECL cell death were also measured by DNA fragmentation ELISA (Fig. 4B) . After 24 h of recovery, ECL cells were treated with vehicle or the different growth factors over 24 h and lysed. The lysates were transferred to 96-well plates in which the OD was measured at 405 nm ( Fig. 4B ; n ϭ 6 independent experiments). Similar results were obtained using the DNA fragmentation ELISA compared with the data generated by the TUNEL reaction. OD ranged from 0.1-0.2 relative units under basal conditions and is shown as a percentage of the change vs. basal density. Gastrin and TGF␣ had no significant effect on ECL cell death. ␤NGF significantly decreased the basal rate (n ϭ 6; P Ͻ 0.01). Again, bFGF (2 ng/ml; P Ͻ 0.01) was the most effective factor tested, and this effect corresponded to the inhibition of cell death measured by the TUNEL reaction.
6) Apoptosis of ECL cells in the presence of proinflammatory cytokines (Fig. 5)
Programmed ECL cell death was also investigated in the presence of the proinflammatory cytokine IL-1␤ and simultaneous addition of gastrin or growth factors. Similar to the experiments performed in Fig. 4 , ECL cell apoptosis was measured by the TUNEL reaction (Fig. 5A) or by DNA fragmentation ELISA (Fig. 5B) . After 24 h of recovery, isolated and cultured ECL cells were treated over 24 h with vehicle, IL-1␤ (100 pg/ml), or IL-1␤ (100 pg/ml) plus gastrin (10 Ϫ11 m), TGF␣ (20 ng/ml), or bFGF (2 ng/ml). Staining for apoptotic cells was determined by the TUNEL reaction (Fig. 5A ) under basal conditions in 4 -6% of ECL cells, similar to the results shown in Fig. 4A . As shown in Fig. 5A , IL-1␤ (100 pg/ml) increased the number of apoptotic cells 3-fold to 12-16% of the total cell number. Therefore, IL-1␤ can be regarded as a potent stimulant of ECL cell apoptosis. Incu- bation of ECL cells with IL-1␤ and gastrin (10 pm) decreased the stimulation of apoptosis by approximately 40%, but this effect did not attain statistical significance using Student's t test. The simultaneous presence of TGF␣ (20 ng/ml; n ϭ 6; P Ͻ 0.01) in IL-1␤-treated samples significantly inhibited the IL-1␤ effect. Most prominently, bFGF (2 ng/ml) reduced the amount of apoptotic ECL cells to 3-4%, corresponding to basal values (n ϭ 6; P Ͻ 0.01 vs. incubation with IL-1␤ alone). For objective quantification of these results, a histoneassociated DNA fragmentation ELISA was used (Fig. 5B) . Identical results were achieved using this technique. IL-1␤ increased the amount of apoptotic cells 2-to 3-fold. Gastrin decreased this effect by approximately 30% (not significant in six experiments). In contrast, TGF␣ (20 ng/ml; n ϭ 6; P Ͻ 0.05) significantly inhibited the induction of apoptosis, and bFGF (2 ng/ml) reduced the apoptotic rate below basal (n ϭ 6; P Ͻ 0.05). (Fig. 6) For detection of autocrine growth factor production, immunocytochemistry of 48-h isolated and cultured ECL cells was performed. For determination of bFGF production, two different antibodies and at least five different fixation methods were used. No staining was detected in isolated ECL cells (total of eight experiments). The Swiss 3T3 cell line served as a positive control. In contrast, autocrine production of TGF␣ was observed in 92% of the counted cells, corresponding to the degree of enrichment. Figure 6a shows isolated ECL cells incubated with an anti-TGF␣ polyclonal antibody and secondary antibody staining using a peroxidase reaction. Figure 6b illustrates a positive control performed with a human pancreatic cell line (LnCaP). Figure 6c demonstrates a negative control performed without addition of the primary antibody (representative of two additional experiments).
7) Autocrine production of bFGF and TGF␣ in ECL cells
Discussion
The number of ECL cells is increased 2-to 3-fold during conditions of chronic gastric inflammation, especially during chronic atrophic gastritis (10 -15, 26) . Two mechanisms may be responsible for this relative increment: 1) the growth of ECL cells is actively stimulated; or 2) the survival rate is prolonged. One major factor for ECL cell proliferation is the antral hormone gastrin (4), which exerts mitogenic effects on ECL cells in vivo and in vitro and which is elevated during conditions of chronic hypochlorhydria (1, 2, 4, 5, 7) . On the other hand, additional growth factors, such as TGF␣, have been detected in extracts of the chronically inflamed gastric mucosa (25, 35, 36) . Autocrine production of bFGF and TGF␣ has been detected in human ECL cell carcinoids (25) (26) (27) . These growth factors might affect ECL cell proliferation by active induction of ECL cell growth or enhancement of cell survival (25, 26) . Finally, it may be possible that the interaction of gastrin or growth factors with proinflammatory cytokines released in the chronically inflamed mucosa (16) prevents ECL cell death during chronic gastritis.
In the present study, we used highly purified rat ECL cells to study the direct effects of agents and to minimize the influence of confounding factors. In rats, ECL cells are the most abundant and display a function similar to that in the human stomach. Moreover, mast cells are absent in rat gastric mucosa and do not interfere (2, 3) . In this recently developed model of isolated ECL cells, it has been shown that gastrin directly stimulates ECL cell replication in vitro (3, 4) . Previously used culture medium, however, contained FBS as an additive (3, 4) . FBS has been shown to contain small amounts of gastrin and poorly standardized concentrations of growth factors, such as FGF and TGF, which complicates the interpretation of results obtained with FBS as a culture additive. FIG. 5 . ECL cell apoptosis in the presence of proinflammatory cytokines and growth factors. A, ECL cell apoptosis measured by the TUNEL reaction in the presence of vehicle, IL-1␤ (100 pg/ml), or IL-1␤ (100 pg/ml) in addition to gastrin (10 Ϫ11 M), TGF␣ (20 ng/ml), or bFGF (2 ng/ml; n ϭ 6). P values are indicated. B, Apoptosis measured by DNA fragmentation ELISA in the presence of vehicle, IL-1␤ (100 pg/ml), or IL-1␤ (100 pg/ml) in addition to gastrin (10 Ϫ11 M), TGF␣ (20 ng/ml), or bFGF (2 ng/ml; n ϭ 6). P values are indicated.
Therefore, we modified our previous technique by using a new culture supplement free of FBS. We observed that progesterone, putresceine, and insulin were essential ingredients in the medium, similar to the conditions used for the culture of chromaffin cells (30) .
In the current study, the total number of cultured ECL cells was measured by mitochondrial formazan formation using the EZ4Y kit. This technique determines the total number of living cells, which is a function of active proliferation and passive cell survival due to prevention of apoptosis. The EZ4Y kit was developed in analogy to standard thymidine or bromodeoxyuridine incorporation procedures. For gastrin, stimulation of formazan production was similar to previous results using BrdU incorporation in ECL cells, indicating that the kit determines an increment in cell number (4) . In addition, the determination of cell number using the EZ4Y kit was consistent with the results of the actual cell counts. Therefore, this technique appears to reflect growth factor effects on cell number rather than only changes in mitochondrial function.
Using the EZ4Y kit, this technique revealed a 2-to 3-fold increase in ECL cell number in response to gastrin. The ED 50 for this growth response to gastrin was 50-fold lower (i.e. 1 pm) than the gastrin concentration that elicited half-maximal stimulation of histamine release (3, 4) . Gastrin did not significantly affect spontaneous or cytokine-induced cell death. Therefore, the increase in ECL cell number in response to gastrin appears to result from active induction of proliferation. Gastrin receptor distribution, receptor affinities, and gastrin effects on cell proliferation observed in the current study corresponded to the observations in vivo (5, 37). Gastrin stimulated cell proliferation 2-to 3-fold in vivo and in vitro within 2-7 days of incubation (4, 23) . Maximally effective concentrations were observed at 50 pm in vivo (38) , which is similar to the concentration used in the current protocol (10 Ϫ11 m).
The focus of the present study was to identify EGF, FGF, and NGF receptor subtypes on normal ECL cells and to investigate the effects of the corresponding ligands, TGF␣, bFGF, and ␤NGF. Antibody staining of ECL cells revealed specific staining for the EGF receptor at the plasma membrane. Staining was verified using PC12 cells as a positive control. The EGF receptor is a 170-kDa transmembrane glycoprotein with tyrosine kinase activity (39) . Many gastric carcinoma tissues coexpress EGF receptor and TGF␣ genes at higher levels than normal gastric mucosa (36, 40, 41) .
Overexpression of EGF receptors or mutation leads to uncontrolled cell division, e.g. in breast tumors (36, 39 -41) . TGF␣ specifically binds to the EGF receptor and plays an important role as an autocrine growth factor in the progression of gastric carcinomas (40) , in naive ECL cells, and in ECL cell tumors (21) . In the current study, we observed the presence of the EGF receptor and of TGF␣ in isolated, untreated ECL cells, suggesting a role for autocrine growth stimulation. After 96 h of incubation, TGF␣ increased the number of isolated ECL cells 2-fold, but failed to augment the response to gastrin. The missing additive effect of TGF␣ in combination with gastrin suggests that these factors may share similar intracellular transduction pathways and/or act in a similar way to increase ECL cell number. TGF␣ had no significant effect on the spontaneous apoptosis of ECL cells, as demonstrated in Fig. 4 . Therefore, it may be speculated that in the presence of TGF␣, the increase in absolute cell number results from induction of cell proliferation, similar to gastrin and consistent with other reports based on BrdU incorporation in ECL cells (21) .
The distribution of the EGF receptor and the corresponding ligand and the maximally effective TGF␣ concentration found in isolated ECL cells appear similar to those in vivo. TGF␣ expression has been detected in malignant and normal rat ECL cells in vivo (37) and in other gastric mucosal or intestinal epithelial cells of rats and guinea pigs (36, 42) . TGF␣ staining has also been observed in the human gastric mucosa at the base of the gastric glands, which is the presumable location of ECL and parietal cells, and has been reported to be a potent mitogen for cells of the gastrointestinal tract (42) . Previous dose-response curves for growth stimulation of gastric mucosal cells with TGF␣ (ED 50 , 1-2 ng/ml) determined a maximal effect between 1-100 ng/ml (43) , which is comparable to our present results. In addition, the presence of the EGF receptor has been detected in the mammalian gastric mucosa (36) and in rat ECL cell carcinoids (37) . Therefore, TGF␣ and the EGF receptor may be important factors for ECL cell proliferation in vivo and in vitro. TGF␣ inhibited IL-1␤-induced cell death (apoptosis), indicating that ECL cell apoptosis during conditions of chronic gastric inflammation is also affected by this growth factor. As we detected autocrine production of TGF␣ in ECL cells, this factor may be of crucial importance for the survival of ECL cells in the presence of proinflammatory cytokines such as IL-1␤.
FGF receptor subtype I was also detected in rat gastric Similar to the effects of TGF␣, bFGF might also play an important role in the survival of ECL cells in the presence of proinflammatory cytokines. bFGF production has been detected in hyperplastic human ECL cells and has been implicated to play an important role in human ECL cell growth in vivo (26) . Due to the results demonstrated in Fig. 3 , bFGF increased the number of isolated ECL cells in culture (2-to 4-fold) and showed an additive response in combination with gastrin. The production of bFGF has been previously localized in human ECL cell carcinoids and in human ECL cells in vivo, especially during continuing hypergastrinemia (26) . Dose-response curves for growth stimulation of BALB or 3T3 cells with bFGF ranged between 1-50 ng/ml (ED 50 , 0.1-0.25 ng/ml), with a maximal effect at 5-10 ng/ml, similar to the concentrations used in this study (48, 49) . Although the presence of bFGF shows a remarkable difference in isolated ECL cells and in vivo, the FGF effects and dose-response curves reported in the current study are consistent with previous observations. The dose-response curves for bFGF and TGF␣ show an inverted U shape, and similar results were observed in previous studies using ECL cells, in which gastrin, TGF␣, or Pituitary Adenylate Cyclase Activating Peptide stimulated ECL cell proliferation (4, 50, 51) . Furthermore, TGF␣ or bFGF stimulated mitogenesis of gastric mucosal cells (52) or Swiss 3T3 fibroblasts in a similar U-shaped concentration curve (48, 49) . Therefore, this effect may be a cell-specific finding in response to the growth factors tested.
bFGF inhibited spontaneous and cytokine-induced apoptosis. This finding is consistent with observations in chromaffin and ovarian cells, in which FGF prevented programmed death and led to a prolonged survival rate (53, 54) . Therefore, bFGF may act in two ways to enhance ECL cell numbers: 1) FGF may prolong ECL cell survival via inhibition of programmed cell death; and/or 2) FGF may act as an active stimulant of ECL cell growth. The prominent effects on cell apoptosis as well as the additive effect of FGF in combination with gastrin might allow the conclusion that the major effect of FGF on ECL cells (in contrast to that of TGF␣ or gastrin) is the inhibition of cell survival.
Autocrine production of bFGF was not detected in normal ECL cells. This finding is surprising because autocrine production of bFGF has been reported for ECL cell tumors and during gastrin-induced hyperplasia of ECL cells in humans (26, 45) . One explanation for the missing detection in ECL cells may be that several isoforms of FGF processed by alternative splicing cannot be detected by the primary antibody, as reported previously (55) . In addition, no rat-specific antibody was available. Finally, FGF may be localized only in the nucleus due to processing procedures and may not be accessible for the primary antibody, similar to observations obtained in neurons (55) . Therefore, autocrine production of FGF cannot be excluded. Alternatively, bFGF may not be an important autocrine growth factor for normal ECL cells, and bFGF production may occur only in malignant tissues, as observed in human endocrine tumors (26) . In this case, bFGF production may be an indicator for malignant transformation.
The NGF receptor in ECL cells was of subtype I. In other cell systems, two distinct NGF receptors have been identified (30) . NGF receptor subtype I is a 140-kDa glycoprotein with high and low affinity status and is recognized as a TRK protooncogene, whereas subtype II is a 75-kDa low affinity receptor without full biological activity (30) . In cultured ECL cells, we were able to detect the presence of the type I NGF receptor on ECL cells. ␤NGF inhibited spontaneous ECL cell apoptosis significantly at a concentration of 10 mg/ml. In PC12 cells, NGF prevented programmed cell death and led to a prolonged survival rate at identical concentrations (54) . ␤NGF did not increase the number of ECL cells significantly and therefore appears to have no effect on cell proliferation, in contrast to chromaffin cells of the adrenal gland, in which proliferating effects of NGF were reported (30) .
The HGF receptor was not detected in ECL cells by RT-PCR. The corresponding ligand of this receptor type is HGF. HGF has been implicated to play a role in the H. pyloriinfected, chronically inflamed gastric mucosa (56) . This factor, however, did not exert any effect on ECL cells. As the corresponding receptor was also missing in ECL cells, HGF does not seem to be of major importance for ECL cell proliferation.
Our present in vitro data support the idea that ECL cell quantity can be affected by stimulation or inhibition of programmed cell death in the presence of cytokines and growth factors. We have previously reported that short term exposure (60 min) of ECL cells to IL-1␤ results in sustained functional impairment and inhibits histamine synthesis (9) . Due to the current results, IL-1␤ induced DNA fragmentation in ECL cells after 24 h of incubation. DNA fragmentation is a characteristic finding occurring during programmed cell death (29, 57) . DNA fragmentation in ECL cells was determined by the TUNEL reaction and histone-associated ELISA. These experimental procedures are independent techniques of measurement of apoptosis, but gave similar results. These results are in accordance with previously published results in islet cells of the pancreas (29) . In this cell type, apoptosis can be induced by the addition of IL-1␤ after 24 h of incubation at concentrations of 10 -100 pg/ml, similar to the conditions applied in the present protocols (9, 29) . Determination of apoptosis by the TUNEL reaction indicated that ECL cells undergo programmed cell death at a low rate (4 -6%) under spontaneous conditions and more prominently in the presence of the proinflammatory cytokine IL-1␤. ECL cell apoptosis and ECL cell DNA strand breaks were detected by specific antibody labeling in 12-16% of ECL cells after incubation with IL-1␤. Therefore, IL-1␤ can be regarded as an active inducer of apoptosis in ECL cells.
We speculate that this interaction detected in isolated ECL cells in vitro may parallel clinical observations in the human gastric mucosa in vivo. During chronic atrophic gastritis, interaction of growth factors and cytokines may play an important role in the survival rate of ECL cells. TGF␣ and bFGF inhibited cell survival more prominently in the presence of IL-1␤. Therefore, it may be speculated that in addition to gastrin, bFGF and TGF␣ should be regarded as important growth factors for ECL cell proliferation and survival and might play an important role in prolonged ECL cell survival during chronic atrophic gastritis.
